EASL Wilson’s Disease Guideline Summary - Guideline Central
Summary of Recommendations
Document Overview

Wilson’s Disease

European Association for the Study of the Liver


Publication Date: Nov 8, 2024

Page Last Updated: May 5, 2026


Level of Evidence and Grades of Recommendation



 

Document Overview

Document Title
Wilson’s Disease
Authoring Society

European Association for the Study of the Liver

Document Publication Date
Nov 8, 2024
Page Last Reviewed/Updated
May 5, 2026
Document Type
Guideline
Country of Publication
European
Full Text Freely Available
Yes
Full Text Guideline
www.journal-of-hepatology.eu/article/S0168-8278(24)02706-5/fulltext
Source Citation

European Association for the Study of the Liver. EASL-ERN Clinical Practice Guidelines on Wilson's disease. J Hepatol. 2025 Feb 22:S0168-8278(24)02706-5. doi: 10.1016/j.jhep.2024.11.007. Epub ahead of print. PMID: 40089450.


Document Scope, Criteria, and Use Cases

Document Objectives

Provide recommendations, based on the best available evidence, for the diagnosis and management of Wilson’s disease (WD) for hepatologists, neurologists, general physicians, paediatricians, specialists in training and other healthcare professionals who provide care for this patient population.

Scope
Diagnosis, Treatment
Diseases/Conditions (MeSH)

D006527 - Hepatolenticular Degeneration

D006527 - Hepatolenticular Degeneration

Keywords
Wilson's disease, hepatolenticular degeneration
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older Adult
Health Care Settings
Ambulatory, Hospital, Laboratory Services
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.